Skeletal muscle size, function, and adiposity with lifelong aerobic exercise.

We examined the influence of lifelong aerobic exercise on skeletal muscle size, function, and adiposity. Young exercisers [YE; n = 20, 10 women (W), 25 ± 1 yr], lifelong exercisers (LLE; n = 28, 7 W, 74 ± 2 yr), and old healthy nonexercisers (OH; n = 20, 10 W, 75 ± 1 yr) were studied. On average, LLE exercised 5 days/wk for 7 h/wk over the past 52 ± 1 yr. The LLE men were subdivided by exercise intensity [Performance (LLE-P), n = 14; Fitness (LLE-F), n = 7]. Upper and lower leg muscle size and adiposity [intermuscular adipose tissue (IMAT)] were determined via MRI, and quadriceps isotonic and isometric function was assessed. For the quadriceps, aging decreased muscle size, isotonic and isometric strength, contraction velocity (men only), and power (P < 0.05). In women, LLE did not influence muscle size or function. In men, LLE attenuated the decline in muscle size and isometric strength by ~50% (P < 0.05). LLE did not influence other aspects of muscle function, nor did training intensity influence muscle size or function. For the triceps surae, aging decreased muscle size only in the women, whereas LLE (both sexes) and training intensity (LLE men) did not influence muscle size. In both sexes, aging increased thigh and calf IMAT by ~130% (P < 0.05), whereas LLE attenuated the thigh increase by ~50% (P < 0.05). In the LLE men, higher training intensity decreased thigh and calf IMAT by ~30% (P < 0.05). In summary, aging and lifelong aerobic exercise influenced muscle size, function, and adipose tissue infiltration in a sex- and muscle-specific fashion. Higher training intensity throughout the life span provided greater protection against adipose tissue infiltration into muscle.NEW & NOTEWORTHY This is the first study to examine skeletal muscle size, function, and adiposity in women and men in their eighth decade of life that have engaged in lifelong aerobic exercise. The findings reveal sex and upper and lower leg muscle group-specific benefits related to skeletal muscle size, function, and adiposity and that exercise intensity influences intermuscular adiposity. This emerging cohort will further our understanding of the health implications of maintaining exercise throughout the life span.

Effect of caffeine intake on pain perception during high-intensity exercise.

Caffeine has been shown to reduce leg-muscle pain during submaximal cycle ergometry, as well as in response to eccentric exercise. However, less is known about its analgesic properties during non-steady-state, high-intensity exercise. The primary aim of this study was to examine the effect of 2 doses of caffeine on leg pain and rating of perceived exertion (RPE) during repeated bouts of high-intensity exercise. Fifteen active men (age 26.4 ± 3.9 yr) completed 2 bouts of 40 repetitions of "all-out" knee extension and flexion of the dominant leg at a contraction velocity equal to 180°/s. Before each trial, subjects abstained from caffeine intake and intense exercise for 48 hr. Over 3 days separated by 48 hr, subjects ingested 1 of 3 treatments (5 mg/kg or 2 mg/kg of anhydrous caffeine or placebo) in a randomized, single-blind, counterbalanced, crossover design. Leg-muscle pain and RPE were assessed during and after exercise using established categorical scales. Across all treatments, pain perception was significantly increased (p < .05) during exercise, as well as from Bout 1 to 2, yet there was no effect (p > .05) of caffeine on pain perception or RPE. Various measures of muscle function were improved (p < .05) with a 5-mg/kg caffeine dose vs. the other treatments. In the 5-mg/kg trial, it is plausible that subjects were able to perform better with similar levels of pain perception and exertion.

Effect of two doses of caffeine on muscular function during isokinetic exercise.

UNLABELLED: Studies provide equivocal results regarding the ergogenic properties of caffeine during high-intensity exercise. PURPOSE: The primary aim of this study was to examine the effects of two doses of caffeine on peak/average torque, power output, and total work of the knee extensors and flexors during two bouts of high-intensity exercise. METHODS: Fifteen active men (mean age = 26.4 ± 3.9 yr and body mass = 82.7 ± 2.9 kg) initially completed a familiarization bout on the isokinetic dynamometer, followed by three subsequent trials separated by at least 48 h. Exercise consisted of two bouts of 40 repetitions of maximal knee extension and flexion of the dominant leg at a contraction velocity equal to 180°·s. Before each trial, subjects abstained from caffeine intake and intense exercise for 48 h. Treatment order (5 and 2 mg·kg of anhydrous caffeine or placebo) was randomly assigned to subjects using a single-blind, randomized, counterbalanced, crossover design. A 3 (treatment) × 2 (sets) ANOVA with repeated measures was used to detect differences in performance across treatment and time. RESULTS: Compared with placebo, caffeine significantly (P < 0.05) enhanced peak knee flexion torque, knee extension/flexion total work, and knee extension/flexion power in bout 1 with no effect in bout 2. Only the 5-mg·kg dose of caffeine improved performance, with the magnitude of performance improvement ranging from 5% to 8%. CONCLUSIONS: Data suggest that a relatively high (5-mg·kg body weight) but not low (2-mg·kg body weight) caffeine dose is ergogenic for maximal knee extension/flexion exercise.